Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Belimumab After Rituximab in Resistant Primary Juvenile SS — Stella

Home/Sjogren's Syndrome/Belimumab After Rituximab in Resistant Primary Juvenile SS

View on ClinicalTrials.gov

Recruiting

Back to Sjogren's Syndrome trials

Belimumab After Rituximab in Resistant Primary Juvenile SS

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(1 site)

China

Peking Union Medical College Hospital, Beijing, Beijing Municipality

Key details

Phase

Post-approval study

Sponsor

Peking Union Medical College Hospital

Collaborators

Children's Hospital of Chongqing Medical University, Central South University

Enrollment target

~15 participants

Started

March 2024

Primary completion

December 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

5 Years – 18 Years

Last updated May 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.